In addition, MCP-4 and PLT levels were lower in stage III of infants with NEC compared to that of stage II, while the expression levels of the other protein biomarkers were higher in the stage III than that of in stage II (Table 4). The gene discussed is CCL13; the disease is necrotizing enterocolitis.